Back to Search Start Over

Effects of N6-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy.

Authors :
Zhu, Yong-fu
Wang, Shu-Jie
Zhou, Jie
Sun, Ye-han
Chen, You-mou
Ma, Jia
Huo, Xing-xing
Song, Hang
Source :
Frontiers in Oncology; 5/30/2022, Vol. 12, p1-9, 9p
Publication Year :
2022

Abstract

N<superscript>6</superscript>-methyladenosine (m<superscript>6</superscript>A) is a major internal epigenetic modification in eukaryotic mRNA, which is dynamic and reversible. m<superscript>6</superscript>A is regulated by methylases ("writers") and demethylases ("erasers") and is recognized and processed by m<superscript>6</superscript>A-binding proteins ("readers"), which further regulate RNA transport, localization, translation, and degradation. It plays a role in promoting or suppressing tumors and has the potential to become a therapeutic target for malignant tumors. In this review, we focus on the mutual regulation of m<superscript>6</superscript>A and coding and non-coding RNAs and introduce the molecular mechanism of m<superscript>6</superscript>A methylation involved in regulation and its role in cancer treatment by taking common female malignant tumors as an example. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
2234943X
Volume :
12
Database :
Complementary Index
Journal :
Frontiers in Oncology
Publication Type :
Academic Journal
Accession number :
157190292
Full Text :
https://doi.org/10.3389/fonc.2022.897895